Report error Found 37 Enz. Inhib. hit(s) with all data for entry = 7641
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 5nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 61nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 70nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 71nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 71nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 82nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 9(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 85nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 91nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 105nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 108nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
Affinity DataIC50: 145nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 232nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 255nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 428nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 900nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication Protein Eng Des Sel, 2006, 19, 155-161) and is added so as to hav...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 3.09E+3nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 6.13E+3nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 6.41E+3nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 9.95E+3nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 9(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 9(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 9(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
TargetDisintegrin and metalloproteinase domain-containing protein 9(Human)
Galderma Research & Development
US Patent
Galderma Research & Development
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are tested in dose-response studies on the following enzymes MMP1, MMP3, MMP9, ADAM9 and ADAM10 according to the same protocol as that ...More data for this Ligand-Target Pair
